OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
Guideline 420 was adopted in July 1992 as the first alternative to the conventional acute toxicity test.
This presentation will help understanding the vast process of rat and mice handling and oral routes of drug administration through acute class method (OECD: 423).
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
Guideline 420 was adopted in July 1992 as the first alternative to the conventional acute toxicity test.
This presentation will help understanding the vast process of rat and mice handling and oral routes of drug administration through acute class method (OECD: 423).
Subacute toxicity study
These slides will be helpful for M.Pharm 2nd semester Pharmacology students to prepare for the subject " Toxicological Screening Methods" as per PCI new syllabus regulations
toxicology study according to OECD guidelines, organisation for economic co-orporation and developement, jasdeep singh , maharaja ranjit singh punjab technical university bathinda
Introduction to pre clinical screening of drugsKanthlal SK
Various Techniques and Methods for screening of new chemical entities in preclinical aspects (both invitro & invivo) for effective and safe clinical usage.
Assignment on Toxicokinetics- Toxicokinetic evaluation in preclinical studies, saturation kinetics Importance and applications of toxicokinetic studies. Alternative methods to animal toxicity testing.
genotoxicity describes the property of chemical agents that damages the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, whereas not all genotoxic substances are mutagenic
Dear Friends,
This is my 3rd presentation, which will help you to understand the depth knowledge of acute eye irritation/corrosion (OECD-405) study in rabbit.
REPRODUCTIVE TOXICITY STUDIES, Definition
Introduction, OECD guidelines for reproductive toxicity studies
Principle of the test, Description of Method, Procedure, Experimental Schedule, Data and Reporting, Results, Male Fertility Toxicological Studies
Ms. I. Sai Reddemma.
Department of Pharmacology
Subacute toxicity study
These slides will be helpful for M.Pharm 2nd semester Pharmacology students to prepare for the subject " Toxicological Screening Methods" as per PCI new syllabus regulations
toxicology study according to OECD guidelines, organisation for economic co-orporation and developement, jasdeep singh , maharaja ranjit singh punjab technical university bathinda
Introduction to pre clinical screening of drugsKanthlal SK
Various Techniques and Methods for screening of new chemical entities in preclinical aspects (both invitro & invivo) for effective and safe clinical usage.
Assignment on Toxicokinetics- Toxicokinetic evaluation in preclinical studies, saturation kinetics Importance and applications of toxicokinetic studies. Alternative methods to animal toxicity testing.
genotoxicity describes the property of chemical agents that damages the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, whereas not all genotoxic substances are mutagenic
Dear Friends,
This is my 3rd presentation, which will help you to understand the depth knowledge of acute eye irritation/corrosion (OECD-405) study in rabbit.
REPRODUCTIVE TOXICITY STUDIES, Definition
Introduction, OECD guidelines for reproductive toxicity studies
Principle of the test, Description of Method, Procedure, Experimental Schedule, Data and Reporting, Results, Male Fertility Toxicological Studies
Ms. I. Sai Reddemma.
Department of Pharmacology
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Acute toxicity studies-425
1. ACUTE TOXICITY STUDIES
AS PER OECD GUIDELINES
PREPARED BY : JESHICA P. BULSARA
M.PHARM SEM II
DEPARTMENT OF PHARMACOLOGY
SSR COLLEGE OF PHARMACY,SAYLI,SILVASSA
2. TOXICOLOGY
Toxicology is the scientific study of adverse
effects that occur in living organisms due to
chemicals.
It involves observing and reporting
symptoms, mechanisms, detection and
treatments of toxic substances, in particular
relation to the poisoning of humans.
Toxicity tests are mostly used to examine
specific adverse events such as cancer,
cardiotoxicity and skin/eye irritation
3. ANIMAL TOXICITY TEST
Acute toxicity 14 days
Sub-acute (repeated doses) toxicity 28 days
Sub-chronic toxicity 3 months
Chronic toxicity 6 months to 2 yrs.
Special toxicity e.g. Carcinogenicity
4. ACUTE ORAL TOXICITY
Acute toxicity testing is carried out to determine the effect of a single dose on a
particular animal species.
In acute toxicological testing, the investigational product is administered at different
dose levels, and the effect is observed for 14 days.
All mortalities caused by the investigational product during the experimental period are
recorded and morphological, biochemical, pathological, and histological changes in the
dead animals are investigated.
Acute toxicity testing permits the 50% lethal dose (LD50) of the investigational product
to be determined.
Acute toxicity studies provide information on:
• The potential for acute toxicity in humans;
• An estimate of safe acute doses for humans;
• The potential target organs of toxicity;
• Time course of drug-induced clinical observations;
• The appropriate dosage for multiple-dose toxicity studies; and
• Species differences in toxicity.
5. OECD GUIDELINES FOR
ACUTE ORAL TOXICITY
Number Title Date of adoption
401 Conventional acute toxicity test Date of deletion:
17 December 2002
420 Fixed dose procedure 17 December 2001
423 Acute toxic class method 17 December 2001
425 Up and down procedure 3 October 2008
6. 425 : Acute oral toxicity – Up and Down
Procedure(UDP)
Introduction
• The concept of the up-and-down testing approach was first described by Dixon and Mood.
• In 1985, Bruce proposed to use an up-and-down procedure (UDP) for the determination of acute
toxicity of chemicals .
• A study comparing the results obtained with the UDP, the conventional LD50 test and the Fixed
Dose Procedure (FDP, OECD Test Guideline 420) was published in 1995.
• The test procedure described in this Guideline is of value in minimizing the number of animals
required to estimate the acute oral toxicity of a chemical. In addition to the estimation of LD50
and confidence intervals, the test allows the observation of signs of toxicity.
7. INITIAL CONSIDERATIONS
:
• The testing laboratory should consider all available information on the test substance
prior to conducting the study.
• It will include
- Identity and chemical structure of the test substance;
- Physical chemical properties;
- Results of any other in vitro or in vivo toxicity tests on the substance;
- Toxicological data on structurally related substances or similar mixtures;
- Anticipated use(s) of the substance.
• This information is useful to determine the relevance of the test for the protection of
human health and the environment, and will help in the selection of an appropriate
starting dose.
• The method permits estimation of an LD50 with a confidence interval and the results
allow a substance to be ranked and classified according to the Globally Harmonised
System for the classification of chemicals which cause acute toxicity.
8. • Dose starting near 175mg/kg and using half log units (dose progression by factor
3.2) between doses will procedure best results.
• Test substances, at doses that are known to cause marked pain and distress due to
corrosive or severely irritant actions, need not be administered.
• Moribund animals or animals obviously in pain or showing signs of severe and
enduring distress shall be humanely killed, and are considered in the interpretation
of the test results in the same way as animals that died on test.
• The method would not be practical to use when considerably delayed death (five
days or more) can be expected.
9. PRINCIPLE OF LIMIT TEST
• The Limit Test is a sequential test that uses a maximum of 5 animals. A test dose of
2000, or exceptionally 5000 mg/kg, may be used.
• The selection of a sequential test plan increases the statistical power and also has
been made to intentionally bias the procedure towards rejection of the limit test for
compounds with LD50s near the limit dose.
PRINCIPLE OF MAIN TEST
• The main test consists of a single ordered dose progression in which animals are
dosed, one at a time, at a minimum of 48-hour intervals.
• The first animal receives a dose a step below the level of the best estimate of the
LD50.
10. • If the animal survives, the dose for the next animal is increased by [a factor of]
3.2 times the original dose; if it dies, the dose for the next animal is decreased
by a similar dose progression.
• Each animal should be observed carefully for up to 48 hours before making a
decision on whether and how much to dose the next animal.
• That decision is based on the 48-hour survival pattern of all the animals up to
that time.
• The LD50 is calculated using the method of maximum likelihood
11. DESCRIPTION OF METHOD
Selection of animal species
• The preferred rodent species is the rat ,normally female rats are used.
• When toxicological or toxicokinetic properties of structurally related chemicals
are studied, males are likely to be more sensitive.
• Criteria for female rats
- They should be nulliparous and non pregnant. -
- Should be between 8 to 12 years old.
- Weight ± 20% of initial mean weight
12. Housing and feeding
• Temperature - 22°C (± 3°C).
• Humidity – 50 – 60% not exceeding 70%
• Lighting should be artificial, the sequence being 12 hours light and 12
hours dark.
• The animals are housed individually.
• For feeding, conventional rodent laboratory diets may be used with an
unlimited supply of drinking water.
13. Preparation of animals
• The animals are randomly selected, marked to permit individual
identification, and kept in their cages for at least 5 days prior to dosing to
allow for acclimatization to laboratory conditions.
• Ensure that animals are available in the appropriate size and age range for
the entire study.
Preparation of doses
• Test substances should be administered in a constant volume by varying the
concentration of the dosing preparation.
• In rodents, the volume should not normally exceed 1 ml/100g of body weight;
however in the case of aqueous solutions, 2 ml/100g body weight can be
considered.
• For vehicles other than water, the toxicological characteristics of the vehicle
should be known.
14. PROCEDURE
Administration of Doses
• The test substance is administered in a single dose by gavage using a
stomach tube or a suitable intubation cannula.
• Animals should be fasted prior to dosing (e.g., with the rat, food but not
water should be withheld overnight; with the mouse, food but not water
should be withheld for 3-4 hours).
• The animals should be weighed and the test substance administered and
the dose is calculated according to the body weight.
• After the substance has been administered, food may be withheld for a
further 3-4 hours in rats or 1-2 hours in mice.
15. Limit test and Main Test
• The limit test is primarily used in situations where the experimenter has
information indicating that the test material is likely to be nontoxic, i.e.,
having toxicity below regulatory limit doses.
• There is little or no information about its toxicity, or in which the test
material is expected to be toxic, the main test should be performed.
• Information about the toxicity of the test material can be gained from
knowledge about similar tested compounds or similar tested mixtures or
products, taking into consideration the identity and percentage of
components.
16. Limit Test
Limit Test at 2000 mg/kg
• Dose one animal at the test dose.
• If the animal dies, conduct the main test to determine the LD50.
• If the animal survives, dose four additional animals sequentially so that a total
of five animals are tested. If three animals die, the limit test is terminated and
the main test is performed.
• If an animal unexpectedly dies late in the study, and there are other survivors,
it is appropriate to stop dosing and observe all animals to see if other animals
will also die during a similar observation period.
• The results are evaluated as follows (O=survival, X=death).
17. • The LD50 is less than the test dose (2000 mg/kg) when three or more
animals die.
O XO XX
O OX XX
O XX OX
O XX X
If a third animal dies, conduct the main test.
• Test five animals. The LD50 is greater than the test dose (2000
mg/kg) when three or more animals survive.
O OO OO
O OO XO
O OO OX
O OO XX
O XO XO
O XO OO/X
O OX XO
O OX OO/X
O XX OO
18. Limit Test at 5000 mg/kg
• Dose one animal at the test dose.
• If the animal dies, conduct the main test to determine the LD50.
• If the animal survives, dose two additional animals. If both animals survive, the
LD50 is greater than the limit dose and the test is terminated.
• The LD50 is less than the test dose (5000 mg/kg) when three or more animals die.
O XO XX
O OX XX
O XX OX
O XX X0.
The LD50 is greater than the test dose (5000 mg/kg) when three or more animals
survive.
O OO
O XO XO
O XO O
O OX XO
O OX O
O XX OO
19. Main Test
• Single animals are dosed in sequence usually at 48 h intervals.
• For selecting the starting dose, information on structurally related
substances and results of any other toxicity tests on the test material,
should be used to approximate the LD50 as well as the slope of the dose-
response curve.
• The dose progression factor should remain constant throughout testing.
• When there is no information on the slope of the substance to be tested, a
dose progression factor of 3.2 is used.
• Using the default progression factor, doses would be selected from the
sequence 1.75, 5.5, 17.5, 55, 175, 550, 2000 (or 1.75, 5.5, 17.5, 55, 175,
550, 1750, 5000 for specific regulatory needs).
20. 1 animal
1.75mg/kg
If the animal
survives
If the animal dies
Next animal receives the higher dose
5.5mg/kg
Classify GHS
category 1
1 animal
5.5mg/kg
If the animal survives If the animal dies
Next animal receives the higher dose
17.5mg/kg
Animal receives lower
dose
21. • The testing stops when one of the following stopping criteria first is met:
(a) 3 consecutive animals survive at the upper bound;
(b) 5 reversals occur in any 6 consecutive animals tested;
(c) at least 4 animals have followed the first reversal and the specified
likelihood-ratios exceed the critical value.
• If an animal unexpectedly dies late in the study and there are other survivors at that
dose or above, it is appropriate to stop dosing and observe all animals to see if
other animals will also die during a similar observation period.
• If subsequent survivors also die, and it appears that all dose levels exceed the LD50
it would be most appropriate to start the study again.
• If subsequent animals survive at or above the dose of the animal that dies, it is not
necessary to change the dose progression.
22. OBSERVATIONS
• Animals are observed individually at least once during the first 30 minutes after
dosing, periodically during the first 24 hours for 14 days.
• The times at which signs of toxicity appear and disappear are recorded.
• Observations should include
- changes in skin and fur
- eyes and mucous membranes
- respiratory, circulatory
- autonomic and central nervous systems
- somatomotor activity
- behaviour pattern
- tremors, convulsions
- salivation
- diarrhoea
- lethargy
- sleep and coma.
• Animals found in a moribund condition and animals showing severe pain or enduring
signs of severe distress should be humanely killed and time of death should be
recorded.
23. Pathology
• Individual weights are recorded before the test drug administration and weekly
thereafter.
• At the end of the test surviving animals are weighed and then humanely killed.
Bodyweigh
t
• All animals (including those which die during the test or are removed from the
study for animal welfare reasons) should be subjected to gross necropsy.
• Microscopic examination of organs showing evidence of gross pathology in
animals surviving 24 or more hours after the initial dosing may also be
considered.
24. DATA AND REPORTING
All data should be summarized in tabular form, showing for each test dose,
- number of animals used
- number of animals displaying signs of toxicity
- number of animals found dead during the test or killed for humane reasons
- time of death of individual animals
- a description and the time course of toxic effects and reversibility
- necropsy findings.
CALCULATION OF LD 50
The LD50 is calculated using the maximum likelihood method
Likelihood function is written as follows:
L = L1 L2 ....Ln ,
where L is the likelihood of the experimental outcome, µ and σ, and n the total
number of animals tested.
25. Li = 1 - F(Zi) ,if the ith animal survived, or
Li = F(Zi) if the ith animal died,
where F = cumulative standard normal distribution,
Zi = [log(di) - µ ] / σ
di = dose given to the ith animal
σ = standard deviation in log units of dose (usually 0.5)
Estimated LD50 are available for these circumstances given below:
a) If the upper bound dose ended testing, then the LD50 is reported to be above the upper
bound.
b) If all the dead animals have higher doses than all the live animals, then the LD50 is
between the doses for the live and the dead animals which do not give exact value of
LD50.
c) If the live and dead animals have only one dose in common and all the other dead
animals
have higher doses and all the other live animals lower doses, or vice versa, then the LD50
equals their common dose.• Maximum likelihood calculation can be performed using either SAS (e.g., PROC
NLIN) or BMDP (e.g., program AR) computer program packages.
26. Computation of Confidence Interval
Confidence intervals provides valuable information on the reliability and utility of the
main test that was conducted
• A wide confidence interval indicates that there is more uncertainty associated
with the estimated LD50. The reliability of the estimated LD50 is low and the
usefulness of the estimated LD50 may be marginal.
• A narrow interval indicates that there is relatively little uncertainty associated
with the estimated LD50. The reliability of the estimated LD50 is high and the
usefulness of the estimated LD50 is good.
• This means that if the main test were to be repeated, the new estimated LD50
should be close to the original estimated LD50 and both of these estimates
should be close to the true LD50.
27. TEST REPORT
The test report must include the following information:
• Test substance:
− physical nature, purity and, where relevant, physical-chemical properties (including
isomerization);
− identification data, including CAS number.
• Vehicle (if appropriate):
− justification for choice of vehicle, if other than water.
• Test animals:
− species/strain used;
− microbiological status of the animals, when known;
− number, age and sex of animals (including, where appropriate, a rationale for use of males
instead of females);
− source, housing conditions, diet, etc.
28. • Test conditions:
− rationale for initial dose level selection, dose progression factor and for follow-up dose
levels;
− details of test substance formulation including details of the physical form of the material
administered;
− details of the administration of the test substance including dosing volumes and time of
dosing;
− details of food and water quality (including diet type/source, water source).
• Results:
− body weight/body weight changes;
− tabulation of response data and dose level for each animal (i.e., animals showing signs of
toxicity including nature, severity, duration of effects, and mortality);
− individual weights of animals at the day of dosing, in weekly intervals thereafter, and at
the time of death or sacrifice ;
− time course of onset of signs of toxicity and whether these were reversible for each animal;
− necropsy findings and any histopathological findings for each animal, if available; − LD50
data;
− statistical treatment of results.
29. Comparison of guidelines
Criteria 420 423 425
Dose 5 to 5000 mg/kg 5 to 5000 mg/kg 1st animal dose less
than estimated LD50
outcome by factor 3.2
Grouping of animal Group of 5 animal
of one sex
Three animals per
group
One animal per group
Estimation of end
point
1 animal expected
to die
2-3 animal
expected to die
2-3 animal expected
to die
Sighting study Present Absent Absent
30. 1. Dixon W.J. and A.M. Mood. (1948). A Method for Obtaining and Analyzing
Sensitivity Data. J. Amer. Statist. Assoc., 43, 109-126.
2. Dixon W.J. The Up-and-Down Method for Small Samples (1965). J. Amer. Statist.
Assoc. 60, 967-978.
References
3. Bruce R.D. (1985). An Up-and-Down Procedure for Acute Toxicity Testing.
Fundam.
Appl. Tox., 5, 151-157.
4. ASTM (1987). E 1163-87, Standard Test Method for Estimating Acute Oral
Toxicity
in Rats. American Society for Testing and Materials, Philadelphia Pa, USA.5.OECD (2000). Guidance Document on Acute Oral Toxicity . Environmental Health
and Safety Monograph Series on Testing and Assessment No 24.
6. OECD (2000). Guidance Document on the Recognition, Assessment and Use of
Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety
Evaluation. Environmental Health and Safety Monograph Series on Testing and
Assessment No 19.